CRLS1
Basic information
Region (hg38): 20:6006093-6040053
Previous symbols: [ "C20orf155" ]
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 57 (Limited), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 57 (Strong), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 57 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Combined oxidative phosphorylation deficiency 57 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Neurologic; Ophthalmologic | 35147173 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (39 variants)
- not_provided (3 variants)
- Combined_oxidative_phosphorylation_deficiency_57 (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRLS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000019095.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 37 | 42 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 3 | 0 | 37 | 5 | 0 |
Highest pathogenic variant AF is 0.0000075787016
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CRLS1 | protein_coding | protein_coding | ENST00000378863 | 7 | 33964 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00311 | 0.951 | 125715 | 0 | 19 | 125734 | 0.0000756 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.472 | 100 | 114 | 0.876 | 0.00000553 | 1876 |
| Missense in Polyphen | 38 | 46.265 | 0.82136 | 682 | ||
| Synonymous | 0.616 | 35 | 40.0 | 0.876 | 0.00000195 | 640 |
| Loss of Function | 1.74 | 6 | 12.7 | 0.472 | 7.60e-7 | 177 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000131 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000163 | 0.000163 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000115 | 0.000114 |
| Middle Eastern | 0.000163 | 0.000163 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the synthesis of cardiolipin (CL) (diphosphatidylglycerol) by specifically transferring a phosphatidyl group from CDP-diacylglycerol to phosphatidylglycerol (PG). CL is a key phospholipid in mitochondrial membranes and plays important roles in maintaining the functional integrity and dynamics of mitochondria under both optimal and stress conditions. {ECO:0000269|PubMed:16547353, ECO:0000269|PubMed:16678169}.;
- Pathway
- Glycerophospholipid metabolism - Homo sapiens (human);Phospholipid Biosynthesis;Acyl chain remodelling of PG;Metabolism of lipids;cardiolipin biosynthesis;Metabolism;Synthesis of CL;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.138
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- N
- hipred_score
- 0.267
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.989
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crls1
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- cardiolipin biosynthetic process;phosphatidylglycerol acyl-chain remodeling;glycerophospholipid biosynthetic process;response to thyroxine;response to phosphatidylethanolamine
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;cardiolipin synthase activity;CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity;2-acylglycerol-3-phosphate O-acyltransferase activity